MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Dominguez Mozo, Maria Inmaculada ^a   Garcia Montojo, Marta ^a   De Las Heras, Virginia ^a   Garcia Martinez, Angel ^a   Arias Leal, Ana Maria ^a   Casanova, Ignacio ^a   Arroyo, Rafael ^a   Alvarez Lafuente, Roberto ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

HHV 6; Interferon beta; MHC2TA; Multiple sclerosis; Quantitative RT PCR

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; MAJOR CLINICAL STUDY; MALE; MHC2TA GENE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, NEUTRALIZING; FEMALE; GENE FREQUENCY; GENOTYPE; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR PROTEINS; RNA, MESSENGER; ROSEOLOVIRUS INFECTIONS; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 84866548088     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-107     Document Type: Article

References (18)

1. Martínez A, Alvarez-Lafuente R, Mas A, Bartolomé M, García-Montojo M, de Las Heras V, de la Concha EG, Arroyo R, Urcelay E. Environment-gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA. Hum Immunol 2007, 68:685-689. 10.1016/j.humimm.2007.05.005, 17678724.
2. Alvarez-Lafuente R, Martinez A, Garcia-Montojo M, Mas A, De Las Heras V, Dominguez-Mozo MI, Maria Del Carmen C, López-Cavanillas M, Bartolome M, Gomez De La Concha E, Urcelay E, Arroyo R. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur J Neurol 2010, 17:129-135. 10.1111/j.1468-1331.2009.02758.x, 19659749.
3. Hymas W, Stevenson J, Taggart EW, Hillyard D. Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B. J Virol Methods 2005, 128:143-150. 10.1016/j.jviromet.2005.05.003, 15950293.
4. Nitsche A, Müller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W. Human Herpesvirus 6A DNA is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 2001, 183:130-133. 10.1086/317651, 11076708.
5. Pachner AR, Narayan K, Price N, Hurd M, Dail D. MxA gene expression analysis as an interferon-beta bioactivity measurement in patients with multiple sclerosis and the identification of antibody-mediated decreased bioactivity. Mol Diagn 2003, 7:17-25. 10.2165/00066982-200307010-00004, 14529316.
6. Bertolotto A, Sala A, Malucchi S, Marnetto F, Caldano M, Di Sapio A, Capobianco M, Gilli F. Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. J Neurol Neurosurg Psychiatry 2004, 75:1294-1299. 10.1136/jnnp.2004.037259, 1739245, 15314118.
7. Kawade Y. Quantitation of neutralization of interferon by antibody. Methods Enzymol 1986, 119:558-573.
8. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J, Lang R, Martin R, Gold R, Becher B, Brück W, Kalinke U. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686. 10.1016/j.immuni.2008.03.011, 18424188.
9. Itoh T, Horiuchi M, Itoh A. Interferon-triggered transcriptional cascades in the oligodendroglial lineage: a comparison of induction of MHC class II antigen between oligodendroglial progenitor cells and mature oligodendrocytes. J Neuroimmunol 2009, 212:53-64. 10.1016/j.jneuroim.2009.04.021, 2710417, 19467717.
10. Ting JP, Baldwin AS. Regulation of MHC gene expression. Curr Opin Immunol 1993, 5:8-16. 10.1016/0952-7915(93)90074-3, 8452678.
11. Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol 2006, 27:405-412. 10.1016/j.it.2006.07.007, 16870508.
12. Accolla RS, De Lerma Barbaro A, Mazza S, Casoli C, De Maria A, Tosi G. The MHC class II transactivator: prey and hunter in infectious diseases. Trends Immunol 2001, 22:560-563. 10.1016/S1471-4906(01)02003-8, 11574280.
13. Gao J, De BP, Han Y, Choudhary S, Ransohoff R, Banerjee AK. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon. J Virol 2001, 75:1124-1131. 10.1128/JVI.75.3.1124-1131.2001, 114018, 11152485.
14. Le Roy E, Mühlethaler-Mottet A, Davrinche C, Mach B, Davignon JL. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J Virol 1999, 73:6582-6589. 112742, 10400755.
15. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998, 187:675-683. 10.1084/jem.187.5.675, 2212176, 9480977.
16. Lee AW, Wang N, Hornell TM, Harding JJ, Deshpande C, Hertel L, Lacaille V, Pashine A, Macaubas C, Mocarski ES, Mellins ED. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol 2011, 48:1160-1167. 10.1016/j.molimm.2011.02.010, 3086682, 21458073.
17. Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002, 8:237-242. 10.1191/1352458502ms794oa, 12120696.
18. Garcia-Montojo M, De Las Heras V, Dominguez-Mozo M, Bartolome M, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R, HHV-6 and Multiple Sclerosis Study Group Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients. Eur J Neurol 2011, 18:1027-1035. 10.1111/j.1468-1331.2011.03410.x, 21518144, HHV-6 and Multiple Sclerosis Study Group.